BREAKING
Eli Lilly and Company (LLY) to acquire Orna Therapeutics 32 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 hour ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 32 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 hour ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago
ADVERTISEMENT
Market News

MicroVision stock stumbles after reporting Q1 earnings results

MicroVision’s (MVIS) bottom line and topline for Q1 2019 came in line with analysts’ expectations. The company reported a loss of 8 cents per share on revenuve of $1.85 million for the first quarter ended March 31, 2019. On average, analysts had expected MicroVision to post a loss of 8 cents per share on revenue […]

April 17, 2019 2 min read

MicroVision’s (MVIS) bottom line and topline for Q1 2019 came in line with analysts’ expectations. The company reported a loss of 8 cents per share on revenuve of $1.85 million for the first quarter ended March 31, 2019. On average, analysts had expected MicroVision to post a loss of 8 cents per share on revenue of $1.85 million. MVIS stock, which closed up 15.53% at $1.19 yesterday, plunged about 9% in premarket trading hours.

MicroVision Q1 2019 earnings results

Net loss widened to $8.1 million in the recently ended quarter from $7.1 million in the prior-year quarter. Revenue decreased 15% year-over-year to $1.85 million.

“We remain on track with our business plan and are working to have products in the market in the second half of this year. We expect the development portion of our April 2017 agreement with a leading technology company to be completed in Q2 and we expect orders for production units shortly,” said CEO Perry Mulligan.

Total operating expenses increased to $8.67 million from $7.44 million in the first quarter of 2018. Cash and cash equivalents stood at $6.98 million as of March 31, 2019 compared to $13.77 million at the end of December 31, 2018.

ADVERTISEMENT

The Redmond, Washington-based tech firm had stated in the recent annual filing that it had incurred substantial losses since inception and expects to incur a significant loss during the fiscal year ending December 31, 2019.

Shares of MicroVision have jumped 97% since the beginning of 2019 and dropped 8% in the past 12 months period.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

ADVERTISEMENT